World Orphan Drug Congress 2022
Our mission is to facilitate that patients with diseases for which no or only limited treatment options are available receive access to effective treatments. Therefore, SKC will meet with a wide variety of stakeholders from the orphan drug industry at the World Orphan Drug Congress.
Join Prof. Matthias P. Schönermark, M.D., Ph.D., managing director of SKC, and Maciej Gajewski, head of international government affairs and policy at Alexion, on November 15th at the exciting roundtable discussion on "Improving access to OMPs - An international analysis of policy provisions and incentives".
Are you also participating in this event? Please get in touch with us for a personal meeting.